Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
Medecine Sciences : M/S
|
June 4, 2015
[The 2000 years]
Marc Peschanski, Michel Bergeron, André Boué, et al.
Kidney International
|
June 14, 2013
Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families
Binu M Paul, Mark B Consugar, Moonnoh Ryan Lee, et al.
Molecular Genetics and Metabolism
|
December 3, 2009
A validated disease severity scoring system for Fabry disease
Edward H Giannini, Atul B Mehta, Max J Hilz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 19, 2010
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?
Christiane Auray-Blais, Aimé Ntwari, Joe T R Clarke, et al.
Journal of Medical Genetics
|
February 14, 2018
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study
Maarten Arends, Marieke Biegstraaten, Christoph Wanner, et al.
Journal of Medical Genetics
|
March 20, 2016
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
Alberto Ortiz, Ademola Abiose, Daniel G Bichet, et al.
Plos One
|
May 9, 2015
Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial
Frits A Wijburg, Bernard Bénichou, Daniel G Bichet, et al.
Plos One
|
August 8, 2015
Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase
David G Warnock, Daniel G Bichet, Myrl Holida, et al.
Molecular Genetics and Metabolism
|
April 17, 2019
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial
Uma Ramaswami, Daniel G Bichet, Lorne A Clarke, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 23, 2016
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat
Elfrida R Benjamin, Maria Cecilia Della Valle, Xiaoyang Wu, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
Medecine Sciences : M/S
|
June 4, 2015
[The 2000 years]
Marc Peschanski, Michel Bergeron, André Boué, et al.
Kidney International
|
June 14, 2013
Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families
Binu M Paul, Mark B Consugar, Moonnoh Ryan Lee, et al.
Molecular Genetics and Metabolism
|
December 3, 2009
A validated disease severity scoring system for Fabry disease
Edward H Giannini, Atul B Mehta, Max J Hilz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 19, 2010
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?
Christiane Auray-Blais, Aimé Ntwari, Joe T R Clarke, et al.
Journal of Medical Genetics
|
February 14, 2018
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study
Maarten Arends, Marieke Biegstraaten, Christoph Wanner, et al.
Journal of Medical Genetics
|
March 20, 2016
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
Alberto Ortiz, Ademola Abiose, Daniel G Bichet, et al.
Plos One
|
May 9, 2015
Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial
Frits A Wijburg, Bernard Bénichou, Daniel G Bichet, et al.
Plos One
|
August 8, 2015
Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase
David G Warnock, Daniel G Bichet, Myrl Holida, et al.
Molecular Genetics and Metabolism
|
April 17, 2019
Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial
Uma Ramaswami, Daniel G Bichet, Lorne A Clarke, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 23, 2016
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat
Elfrida R Benjamin, Maria Cecilia Della Valle, Xiaoyang Wu, et al.
Page
of 15